Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Simultaneous Care: Linking Palliation to Clinical Trials

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2006 by University of California, Davis.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00283257
First received: January 25, 2006
Last updated: NA
Last verified: January 2006
History: No changes posted
  Purpose

This is a multi-site randomized control trial taking place at six cancer centers. UC Davis is the lead site. Additional performance sites include the City of Hope Medical Center, Fred Hutchinson Cancer Center at the Univ. of Washington, USC Norris Cancer Center, UCSD Cancer Center, and Johns Hopkins Cancer Center. Clinical trial patients and their caregivers who are randomized to the intervention arm of the study are scheduled for three educational sessions. The sessions focus on teaching problem solving skills based on the COPE problem solving model.


Condition Intervention
Solid Tumor
Lymphoma
Behavioral: Patients and caregivers are taught problem solving skills

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: A Randomized Control Trial That Teaches Oncology Clinical Trial Patients and Their Caregivers Problem Solving Skills.

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Estimated Enrollment: 600
Study Start Date: February 2002
Estimated Study Completion Date: June 2007
Detailed Description:

The project introduces and evaluates the effects of a Simultaneous Care Education Intervention, using the COPE model (Creativity, Optimism, Planning and Expert Information) developed by D'Zurilla and Nezu, as one of its key components for cancer patients in Phase I, II and III clinical trials. The SCEI team will use the COPE problem solving educational model to instruct patients on how to problem solve and manage challenges associated not only with the investigational therapy, but also the psychosocial issues that arise from cancer diagnosis, disease progression, treatment, and disease or treatment related symptoms. The educational intervention also sets up a system for regularly contacting the patient and caregiver in order to reinforce what is taught. Patients and caregivers randomized to the intervention arm will receive three education sessions. Patients and designated caregiver will be asked to complete the set of measurement tools approximately every 30 days while enrolled in the study.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • English speaking, must have caregiver who is willing to participate, must be entering a phase 1-3 oncology clinical trial. Must be able to complete first educational session on or before treatment start date. Solid tumor or lymphoma only.

Exclusion Criteria:

  • Non-English speaking, no caregiver available, unable to complete first educational session on or before treatment start date.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00283257

Contacts
Contact: Frederick J Meyers, M.D. 916 734-8596 fred.meyers@ucdmc.ucdavis.edu
Contact: Joan M Blais, MPA 916 734-2187 joan.blais@ucdmc.ucdavis.edu

Locations
United States, California
UC Davis Cancer Center Recruiting
Sacramento, California, United States, 95817
Contact: Frederick J Meyers, MD    916-734-8596    fred.meyers@ucdmc.ucdavis.edu   
Contact: Joan M Blais, MPA    916 734-2187    joan.blais@ucdmc.ucdavis.edu   
Principal Investigator: Frederick J Meyers, MD         
Sponsors and Collaborators
University of California, Davis
Investigators
Principal Investigator: Michael Carducci, M.D. Johns Hopkins University
Principal Investigator: Betty Ferrell, Ph.D City of Hope Medical Center
Principal Investigator: Anthony Back, M.D. Fred Hutchinson Cancer Center, Univ. of Washington
Principal Investigator: Heinz Josef Lenz, M.D. USC Norris Cancer Center
Principal Investigator: Joanne Mortimer, M.D. University of California, San Diego
Study Chair: Frederick J Meyers, MD University of California, Davis
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00283257     History of Changes
Other Study ID Numbers: NCI CA 95260, NCI CA 95260
Study First Received: January 25, 2006
Last Updated: January 25, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Davis:
Problem solving
psychosocial support

ClinicalTrials.gov processed this record on November 23, 2014